Skip to main content
logo
Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0124
+0.0003 (2.48%)
Oct 15, 2025, 3:59 PM EDT

Evofem Biosciences Revenue

Evofem Biosciences had revenue of $4.83M in the quarter ending June 30, 2025, with 15.99% growth. This brings the company's revenue in the last twelve months to $17.27M, down -2.51% year-over-year. In the year 2024, Evofem Biosciences had annual revenue of $19.36M with 6.28% growth.

Revenue (ttm)
17.27M
Revenue Growth
-2.51%
P/S Ratio
0.09
Revenue / Employee
539.69K
Employees
32
Market Cap
1.50M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202419.36M1.15M6.28%
Dec 31, 202318.22M1.38M8.20%
Dec 31, 202216.84M8.59M104.23%
Dec 31, 20218.24M7.80M1,748.43%
Dec 31, 2020446.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Elite Pharmaceuticals105.45M
Glass House Brands221.55M
Veradigm588.02M
Northwest Biotherapeutics1.09M
American Oncology Network1.76B
Silence Therapeutics27.17M
Jushi Holdings256.36M
Nuo Therapeutics1.95M
Revenue Rankings

Evofem Biosciences News

More News